obesity/hypertension/atherosclerotic cardiovascular disease therapeutics (SyndromeX)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameobesity/hypertension/atherosclerotic cardiovascular disease therapeutics (SyndromeX)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsObesityHypertensionAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSyndromex
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSyndromex
Active IndicationsN/A
Inactive IndicationsObesityHypertensionAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A